Clinical Trial Update: Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating a proton pump inhibitor to prevent gastrointestinal ulcers caused by dual antiplatelet therapy after coronary artery bypass grafti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer Induced By Antiplatelet Agent
• Ulcer of the Gastrointestinal Tract

Drugs mentioned

• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastric Ulcer Induced by Antiplatelet Agent, Ulcer of the Gastrointestinal Tract | Phase 4 | Status: WITHDRAWN